RAPT Therapeutics, Inc. — Director's Dealing 2021

Nov 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-11-09

Reporting Person: Lyons-Williams Lori (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-09	Stock Option (right to buy)	$38.28	A	22500	Acquired	2031-11-09	Common Stock (22500)	Direct

Footnotes

F1: The shares subject to the option shall vest in a series of three successive equal annual installments over the three-year period measured from the date of grant.